Unravelling Intestinal Fibrosis in Ulcerative Colitis

计划入组 10 人 · 首次发布于 2024 年 9 月 19 日

Unveiling the Microbial Impact on Intestinal Fibrosis

计划入组 20 人 · 首次发布于 2023 年 10 月 10 日

Biomarkers of Intestinal Fibrosis in Small Bowel Crohn's Disease

计划入组 232 人 · 首次发布于 2019 年 9 月 13 日

Vasoactive intestinal peptide

C₁₄₇H₂₃₇N₄₃O₄₃S

Intestinal trefoil factor

Fibrosis(Apaxen)

Cystic Fibrosis Foundation

United States

AUSTRALASIAN GASTRO-INTESTINAL TRIALS GROUP

Australia

GEDII - GRUPO DE ESTUDO DA DOENÇA INFLAMATÓRIA INTESTINAL

Portugal

Abivax Presents Breakthrough Anti-Fibrotic Data for Obefazimod at ECCO 2026 Alongside Comprehensive Ulcerative Colitis Results

Merck Expands Tulisokibart Clinical Program with Three New Phase 2b Trials Across Immune-Mediated Inflammatory Diseases

Agomab's AGMB-129 Shows Promising Results in Phase 2a Trial for Fibrostenosing Crohn's Disease